Pdt Partners, LLC Rapt Therapeutics, Inc. Transaction History
Pdt Partners, LLC
- $1.02 Billion
- Q3 2024
A detailed history of Pdt Partners, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 36,998 shares of RAPT stock, worth $44,027. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,998
Previous 97,805
62.17%
Holding current value
$44,027
Previous $298,000
75.17%
% of portfolio
0.01%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding RAPT
# of Institutions
104Shares Held
27MCall Options Held
26.7KPut Options Held
2.4K-
Vanguard Group Inc Valley Forge, PA3.16MShares$3.76 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$3.19 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.9 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$2.05 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$1.9 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $35.3M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...